Skip to main content

Find Clinical Trials

Home
Conditions
Narcotic-Related Disorders

Clinical trial condition

Narcotic-Related Disorders

Explore clinical trials studying Narcotic-Related Disorders. Study availability and eligibility vary by location and protocol.

1,300 public trials 198 recruiting studies

Refine in advanced search Browse all conditions

Narcotic-Related Disorders trial results

Completed

Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department

NCT00913770

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Yale University New Haven, Connecticut, United States

Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

Medications for Opioid Use Disorders (MOUD) Via Telemedicine

NCT03566459

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, Connecticut, United States

VA Maine Healthcare System Augusta, Maine, United States

View Trial Details

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

NCT01246401

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +22 more
Locations: Yale University Hartford, Connecticut, United States

Yale University New Haven, Connecticut, United States

Baystate Medical Center Springfield, Massachusetts, United States

View Trial Details

Completed

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR

NCT03559179

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: HealthPartners Bloomington, Minnesota, United States

View Trial Details

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

NCT02294253

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: STARS New York, United States

View Trial Details

Completed

Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression

NCT04301895

Conditions: Acute Pain, Chemically-Induced Disorders, Drug Misuse, +18 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

The Effects of Minocycline in Opioid-maintained Patients

NCT02359006

Conditions: Agnosia, Chemically-Induced Disorders, Mental Disorders, +11 more
Locations: VA Hospital West Haven, Connecticut, United States

View Trial Details

Completed

Behavioral Drug and HIV Risk Reduction Counseling With MMT in China

NCT01389180

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Center for Disease Control & Prevention Wuhan, Hubei, China

View Trial Details

Completed

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

NCT03377855

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +6 more
Locations: The Institute for Family Health New York, United States

Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

NCT01298219

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: North Alabama Research Center Athens, Alabama, United States

Innovative Clinical Trials, Inc. Birmingham, Alabama, United States

Achieve Clinical Research Birmingham, Alabama, United States

Alabama Clinical Therapeutics Birmingham, Alabama, United States

View all 142 locations

View Trial Details